Captor Therapeutics SA
WSE:CTX
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
31.4
84
|
| Price Target |
|
We'll email you a reminder when the closing price reaches PLN.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Net Margin
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Peer Comparison
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| PL |
C
|
Captor Therapeutics SA
WSE:CTX
|
433.6m PLN |
Loading...
|
|
| IN |
A
|
Aaswa Trading and Exports Ltd
BSE:512038
|
23.9T INR |
Loading...
|
|
| UK |
E
|
Eight Capital Partners PLC
F:ECS
|
158.4B EUR |
Loading...
|
|
| US |
G
|
GE Vernova LLC
NYSE:GEV
|
190.6B USD |
Loading...
|
|
| US |
C
|
China Industrial Group Inc
OTC:CIND
|
121B USD |
Loading...
|
|
| US |
|
Schlumberger NV
NYSE:SLB
|
73.4B USD |
Loading...
|
|
| US |
B
|
Baker Hughes Co
NASDAQ:BKR
|
56.2B USD |
Loading...
|
|
| IN |
G
|
GTV Engineering Ltd
BSE:539479
|
4.8T INR |
Loading...
|
|
| US |
C
|
CoreWeave Inc
NASDAQ:CRWV
|
51.3B USD |
Loading...
|
|
| CH |
G
|
Galderma Group AG
SIX:GALD
|
34.6B CHF |
Loading...
|
|
| US |
R
|
Reddit Inc
NYSE:RDDT
|
36.6B USD |
Loading...
|
Market Distribution
| Min | -9 940 700% |
| 30th Percentile | -3.7% |
| Median | 2.9% |
| 70th Percentile | 9.1% |
| Max | 196 605.3% |
Other Profitability Ratios
Captor Therapeutics SA
Glance View
Captor Therapeutics SA engages in the development of protein degradation drugs for cancer and autoimmune diseases. The company is headquartered in Wroclaw, Woj. Dolnoslaskie and currently employs 98 full-time employees. The company went IPO on 2021-04-19. The firm works in the field of neoplastic and autoimmune diseases for which there is no treatment option, or the available methods show therapeutic limitations. The firm covers aspects of early-stage drug development to deliver therapeutics for life-threatening and life-impairing diseases. The broadly applicable Optigrade tm Targeted Protein Degradation (TPD) platform allows for the creation of new drugs.
See Also
Net Margin is calculated by dividing the Net Income by the Revenue.
The current Net Margin for Captor Therapeutics SA is -353.5%, which is above its 3-year median of -376.6%.
Over the last 3 years, Captor Therapeutics SA’s Net Margin has increased from -853.4% to -353.5%. During this period, it reached a low of -872.6% on Sep 30, 2022 and a high of -211.3% on Sep 30, 2024.